eli lilly lawsuit tirzepatide FDA's decision creates uncertainty for patients—and leads to a Eli Lilly seeks to join

Something modifiable is likely limiting your results, whether dose, nutrition, hydration, or a medical factor

[74] To address dysbiosis, we want to start shifting the microbiome in a positive direction by increasing levels of beneficial bacteria, and decreasing levels of pathogenic bacteria

Will my liposuction results last if I regain weight after stopping GLP-1 medications

We are committed to working with our co-counsel to hold Novo Nordisk and Eli Lilly accountable for failing to warn patients of this serious risk. As a Partner at Seeger Weiss, Parvin has litigated some of the most significant pharmaceutical products liability cases in the country